[1]
Olivari, E. 2025. Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Apr. 2025), e2025040. DOI:https://doi.org/10.4084/MJHID.2025.040.